Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis

BJU Int. 2007 Jul:100 Suppl 2:60-2. doi: 10.1111/j.1464-410X.2007.06958.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / secondary
  • Dexamethasone / therapeutic use*
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Somatostatin / analogs & derivatives*

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal
  • Gonadotropin-Releasing Hormone
  • Somatostatin
  • Dexamethasone